Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study

Authors
Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Botti, G Cortino, GR De Rosa, V Comella, G
Citation
G. Frasci et al., Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study, SEMIN ONCOL, 28(3), 2001, pp. 50-56
Citations number
27
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
SEMINARS IN ONCOLOGY
ISSN journal
00937754 → ACNP
Volume
28
Issue
3
Year of publication
2001
Supplement
10
Pages
50 - 56
Database
ISI
SICI code
0093-7754(200106)28:3<50:GATC>2.0.ZU;2-#